Search Results
Test Catalog
DSAC - Overview: Disaccharidase Activity Panel, Tissue
Evaluation of patients who present with signs or symptoms suggestive of disaccharidase disorders This test is not intended for carrier detection.
Interpretation for CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
F9_IS - Overview: Factor IX Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor IX
NEFA - Overview: Free Fatty Acids, Total, Serum
Evaluation of metabolic status of patients with endocrinopathies Monitoring of control of diabetes mellitus Monitoring the effects of therapeutic diet/exercise lifestyle changes
GPI1 - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
GPIC - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
KIBM - Overview: Ki-67(MIB-1), Breast, Semi-Quantitative Immunohistochemistry, Manual
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with breast carcinoma
MAGES - Overview: Myelin-Associated Glycoprotein Autoantibodies, IgM, Serum
Evaluating peripheral neuropathy Evaluating paraproteinemic neuropathy
MTXSG - Overview: Methotrexate Post Glucarpidase, Serum
Monitoring methotrexate concentrations post-glucarpidase therapy Documenting failure to respond that may be due to noncompliance Guiding dosage adjustments in patients with kidney failure
TPIC - Overview: Triosephosphate Isomerase Enzyme Activity, Blood
Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency
AATHI - Overview: Thrombophilia Profile Interpretation
Interpretation of testing performed as part of a profile to evaluate patients with thrombosis or hypercoagulability states including detecting a lupus-like anticoagulant; dysfibrinogenemia; disseminated intravascular...
URAU - Overview: Urea, 24 Hour, Urine
Assessment of protein intake and/or nitrogen balance
SDLDL - Overview: Small Dense Low Density Lipoprotein Cholesterol, Serum
Aiding in risk management of lipoprotein disorders associated with cardiovascular disease when used in conjunction with other lipid measurements and clinical evaluation
THSD7 - Overview: Thrombospondin Type-1 Domain-Containing 7A Antibodies, Serum
Distinguishing primary from secondary membranous nephropathy cases with antibodies against THSD7A
VIP - Overview: Vasoactive Intestinal Polypeptide, Plasma
Detecting vasoactive intestinal polypeptide-producing tumors in patients with chronic diarrheal diseases
ALKLC - Overview: Anaplastic Lymphoma Kinase for Lung Cancer, Immunohistochemistry
Identification of anaplastic lymphoma kinase (ALK) expression Prediction of tumor response to targeted therapy of non-small cell lung carcinomas.
F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time
SCN5A - Overview: Brugada Syndrome, SCN5A Full Gene Analysis, Varies
Providing a genetic evaluation for patients with a personal or family history suggestive of Brugada syndrome Establishing a diagnosis of Brugada syndrome
ADEVL - Overview: Alzheimer Disease Evaluation, Spinal Fluid
Assessment of adults with cognitive impairment being evaluated for Alzheimer disease and other causes of cognitive impairment These assays should not be used to predict the development of dementia or other neurologic conditions or to...
HBEL1 - Overview: Hemoglobin Electrophoresis Evaluation, Blood
Diagnosis and classification of hemoglobin disorders, including thalassemias and hemoglobin variants
GNANG - Overview: Hereditary Angioedema Focused Gene Panel, Next-Generation Sequencing, Varies
Evaluating hereditary angioedema (HAE) with normal C1 inhibitor (C1INH) in patients with a suggestive personal or family history Confirming a diagnosis of HAE with normal C1INH with the identification of a known or suspected...
LUCHM - Overview: LiquidHALLMARK ctDNA and ctRNA
As an alternative to invasive tissue biopsies to assist in tumor profiling for diagnosis, predicting prognosis, and identifying targeted therapies for the treatment and management of patients with a solid tumor This test is not useful for...
Providing a comprehensive genetic evaluation for patients with a personal or family history suggestive of an inborn error of immunity (IEI) associated with immune dysregulation or autoimmunity Establishing a diagnosis of an IEI, allowing...
AAH - Overview: Amyloid A (Hepatic) Immunostain, Technical Component Only
Classification of hepatic adenomas This test is not useful for amyloid typing.
SMACN - Overview: Actin, Smooth Muscle (SMActin) Immunostain, Technical Component Only
Identification of cells expressing the alpha-smooth muscle isoform of actin
BCL6 - Overview: BCL-6 Immunostain, Technical Component Only
Classification of lymphomas
BHSF - Overview: Beta-Human Chorionic Gonadotropin, Quantitative, Spinal Fluid
Aiding in the diagnosis of brain metastases of testicular cancer or extragonadal intracerebral germ cell tumors
ADMA - Overview: Asymmetric Dimethylarginine, Plasma
Assessing the likelihood of future coronary events in patients with coronary heart disease, type II diabetes mellitus, or kidney disease Prompting intervention and assessing improvements among subjects with elevated ADMA and...
AREC - Overview: Androgen Receptor Immunostain, Technical Component Only
Identification of tumors that express androgen receptor
AATRP - Overview: Alpha-1-Antitrypsin Immunostain, Technical Component Only
Identification of abnormal accumulation of alpha-1-antitrypsin
F_11 - Overview: Coagulation Factor XI Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XI Investigating prolonged activated partial thromboplastin time
F_10 - Overview: Coagulation Factor X Activity Assay, Plasma
Diagnosing deficiency of coagulation factor X, congenital or acquired Evaluating hemostatic function in liver disease Investigation of prolonged prothrombin time or activated partial thromboplastin time
CARBG - Overview: Carbamazepine-10,11-Epoxide, Serum
Monitoring patients exhibiting symptoms of carbamazepine toxicity whose total serum carbamazepine concentration is within the therapeutic range, but who may be producing significant levels of the active metabolite epoxide, which can...
CD303 - Overview: CD303 (BDCA-2) Immunostain, Technical Component Only
Diagnosis of blastic plasmacytoid dendritic cell neoplasm
CD200 - Overview: CD200 (OX2) Immunostain, Technical Component Only
Identifying the presence of CD200 (OX2) protein within chronic lymphocytic leukemia, small lymphocytic lymphoma, hairy cell leukemia, and primary mediastinal large B-cell lymphoma
HNF1B - Overview: Hepatocyte Nuclear Factor 1Beta Immunostain, Technical Component Only
Diagnosis of ovarian clear cell carcinoma and endometrial clear cell carcinoma
HIBSG - Overview: Haemophilus influenzae Type B Antibody, IgG, Serum
Assessing a patient's immunological (IgG) response to Haemophilus influenzae type B (HIB) vaccine Assessing immunity against HIB Aiding in the evaluation of immunodeficiency when the patient is tested pre- and post-vaccination
HEPBS - Overview: Hepatitis B Surface (HBs) Antigen Immunostain, Technical Component Only
Aiding in the identification of hepatitis B infection (carrier state)
HEPAT - Overview: Hepatocyte Immunostain, Technical Component Only
Distinguishing hepatocellular carcinoma from other types of cancer
INSUL - Overview: Insulin Immunostain, Technical Component Only
Identification of normal pancreatic islet beta cells and insulin secreting islet cell tumors
CALRC - Overview: Calreticulin ex9mut Immunostain, Technical Component Only
Identifying the presence of CALR exon 9 frameshift alterations in myeloproliferative neoplasms
CD2 - Overview: CD2 Immunostain, Technical Component Only
Determining T-cell lineage
CD23 - Overview: CD23 Immunostain, Technical Component Only
Identification of follicular dendritic cells Classification of low-grade B-cell lymphomas
CD31 - Overview: CD31 Immunostain, Technical Component Only
Marker of endothelial cells
CD10 - Overview: CD10 Immunostain, Technical Component Only
Phenotyping leukemias and lymphomas
CD13 - Overview: CD13 Immunostain, Technical Component Only
Marker of myeloid lineage
CARNP - Overview: Carbapenemase Detection-Carba NP Test, Varies
Confirming carbapenemase production from pure isolates of Enterobacterales or Pseudomonas aeruginosa
CDTA - Overview: Carbohydrate Deficient Transferrin, Adult, Serum
Indicating chronic alcohol abuse This test is not appropriate for screening patients for congenital disorders of glycosylation.
CALX - Overview: CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN), Reflex, Varies
Aiding in the distinction between a reactive cytosis and a chronic myeloproliferative disorder Evaluating mutations in CALR in an algorithmic process for the MPNR / Myeloproliferative Neoplasm, JAK2 V617F with Reflex to CALR and MPL,...
ANCA2 - Overview: Cytoplasmic Neutrophil Antibodies, Inflammatory Bowel Disease Panel, Serum
Measurement of antineutrophil cytoplastic antibodies as a part of a profile to aid in distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and...
Site Search
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient...
Algorithms - Mayo Clinic Laboratories
B C D E F G H I J K L M
united-states-shipping-guide.pdf
U N ITED STATES SH IPPIN G G U ID E TRANSPORTING SPECIMENS WITHIN THE UNITED STATES 2 | UNITED STATES SHIPPING GUIDE UNITED STATES SHIPPING GUIDE | 2 TABLE OF CONTENTS STEP ONE | DANGEROUS...
U N ITED STATES C O U RIER SH IPPIN G G U ID E TRANSPORTING SPECIMENS WITHIN THE UNITED STATES 2 | UNITED STATES SHIPPING GUIDE THIS GUIDE HAS BEEN DEVELOPED TO MEET THE FOLLOWING OBJECTIVES: •...
critical-values-semi-urgent-results-list.pdf
Thromboplastin Time, Plasma Any – ≥ 150 sec Fibrinogen Any ≤ 60 – mg/dL 0 – 7 weeks ≤ 6.0 ≥ 24.0 g/dL > 7 weeks ≤ 6.0 ≥ 20.0 g/dL INR (International Normalizing Ratio......